ArticleArchives of orthopaedic and trauma surgery2025
Bipolar disorder medications are associated with increased odds of fracture nonunion.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this study was to assess the odds of nonunion for open and closed fractures in patients with bipolar disorder (BD) and characterize any confounding effect of medication prescription. MATERIALS AND
methodsThis was a retrospective cohort study with data sourced from the TriNetX Research database. Our query was for patients that are ≥ 18 years old with extremity long bone fractures with and without prior BD diagnosis. A 1:1 propensity score matching method, matching for age; sex; nicotine use; long-term NSAID use; long-term opioid use; and prior diagnoses of obesity, osteoporosis, and the Charlson comorbidities, was used to create reference groups. The primary outcome was fracture nonunion. Odds of fracture nonunion of the observed groups were compared to the control groups using an odds ratio (OR) with 95% confidence interval (CI).
resultsA total of 1,824,610 patients with long bone fractures were analyzed, with 2.8% having BD. The nonunion rate was higher in patients with BD (3.9%) than those without BD (3.2%, P < .001). The highest nonunion rates were observed in open fractures at 5.1-16.2%, with no significant difference between patients with and without BD (OR 1.04, 95% CI 0.89-1.22). Closed fractures had nonunion rates of 1.6-5.4%, with BD patients showing 1.30 times higher odds (95% CI 1.21-1.41). In BD patients, having a medication prescription for treatment of BD increased the odds of nonunion in closed fractures by 1.68 times (95% CI 1.50-1.88) when compared to those without medication prescription. When patients prescribed medications were removed, BD patients no longer had significantly different odds of nonunion in closed fractures (OR 1.07, 95% CI 0.95-1.21).
conclusionsPharmacological prescriptions for BD, but not BD itself, were associated with significantly increased odds of nonunion in closed fractures, while open fractures were unaffected. Orthopaedic surgeons should consider these increased odds when treating these patients and tailor fracture treatment strategies accordingly.
Indexed as
Identifiers
41105266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.